AAPL 250.9362 1.1636% MSFT 439.85 0.5624% NVDA 132.26 2.5987% GOOGL 190.36 1.0403% GOOG 191.585 0.7547% AMZN 224.7026 1.8967% META 605.1 1.3245% AVGO 221.57 -0.9167% TSLA 434.8 -1.211% TSM 195.3 -0.133% LLY 758.87 -0.7637% V 315.9 1.9756% JPM 234.325 1.7168% UNH 493.79 -1.1867% NVO 103.7 -2.1329% WMT 93.89 0.3634% LVMUY 130.52 0.7721% XOM 105.67 -0.7048% LVMHF 649.5 0.6649% MA 526.755 1.3068%
Last update at 2024-03-06T14:30:00Z
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | 18.08M | 23.08M | 18.78M | 23.70M | 18.11M |
Minority interest | - | - | - | - | - |
Net income | 15.87M | 18.43M | 14.25M | 20.47M | 17.63M |
Selling general administrative | 56.19M | 50.02M | 46.13M | 43.92M | 47.27M |
Selling and marketing expenses | 27.13M | 21.98M | 24.18M | 27.77M | 30.71M |
Gross profit | 154.44M | 140.88M | 136.25M | 144.15M | 149.73M |
Reconciled depreciation | 23.33M | 16.87M | 13.33M | 12.41M | 12.28M |
Ebit | 22.78M | 24.71M | 21.05M | 24.58M | 25.68M |
Ebitda | 47.29M | 43.11M | 35.88M | 37.80M | 37.97M |
Depreciation and amortization | 24.51M | 18.40M | 14.82M | 13.22M | 12.28M |
Non operating income net other | -4.70200M | -1.63100M | -2.27000M | - | -6.77400M |
Operating income | 22.78M | 24.71M | 21.05M | 24.58M | 24.88M |
Other operating expenses | 303.87M | 255.92M | 243.43M | 250.05M | 255.53M |
Interest expense | 6.32M | 3.16M | 3.56M | 6.69M | 7.58M |
Tax provision | 2.21M | 4.65M | 4.54M | 3.23M | 0.48M |
Interest income | - | - | - | 6.69M | 7.58M |
Net interest income | -6.32000M | -3.16000M | -3.56200M | -6.69400M | -7.57700M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 2.21M | 4.65M | 4.54M | 3.23M | 0.48M |
Total revenue | 326.65M | 280.63M | 264.49M | 274.63M | 280.41M |
Total operating expenses | 131.65M | 116.17M | 115.19M | 119.56M | 124.85M |
Cost of revenue | 172.21M | 139.75M | 128.24M | 130.49M | 130.68M |
Total other income expense net | -4.70200M | -1.63200M | -2.27000M | -0.88700M | 0.80M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | 15.87M | 18.43M | 14.25M | 20.47M | 17.63M |
Net income applicable to common shares | 15.87M | 18.43M | 14.25M | 19.70M | 17.63M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Total assets | 430.96M | 383.35M | 326.27M | 339.59M | 327.75M |
Intangible assets | 129.26M | 106.85M | 74.90M | 83.11M | 86.23M |
Earning assets | - | - | - | - | - |
Other current assets | 10.34M | 11.19M | 8.37M | 5.86M | 5.05M |
Total liab | 199.25M | 160.78M | 126.27M | 155.24M | 167.96M |
Total stockholder equity | 231.71M | 222.57M | 200.00M | 184.35M | 159.78M |
Deferred long term liab | 12.76M | 3.87M | 10.38M | 1.77M | 4.88M |
Other current liab | 22.69M | 22.43M | 18.14M | 16.07M | 16.15M |
Common stock | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M |
Capital stock | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M |
Retained earnings | 53.92M | 38.05M | 19.62M | 9.71M | -5.02400M |
Other liab | 12.76M | 13.88M | 10.38M | 7.62M | 4.88M |
Good will | 198.25M | 177.71M | 150.22M | 150.22M | 140.45M |
Other assets | 11.44M | 11.11M | 24.08M | 20.04M | 20.26M |
Cash | 6.95M | 11.43M | 12.67M | 7.36M | 5.73M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 44.45M | 46.43M | 37.44M | 41.93M | 38.50M |
Current deferred revenue | 11.59M | 11.53M | 8.13M | 8.63M | 10.20M |
Net debt | 138.23M | 93.43M | 69.24M | 106.76M | 125.34M |
Short term debt | 3.14M | 4.39M | 3.46M | 8.43M | 6.49M |
Short long term debt | 3.14M | 4.39M | 3.46M | 8.43M | 6.49M |
Short long term debt total | 145.18M | 104.86M | 81.91M | 114.12M | 131.07M |
Other stockholder equity | 177.78M | 184.50M | 180.36M | 174.62M | 170.44M |
Property plant equipment | 9.88M | 18.69M | 13.14M | 19.39M | 10.88M |
Total current assets | 74.56M | 69.00M | 67.14M | 66.83M | 69.94M |
Long term investments | 3.31M | 7.23M | 11.48M | - | 19.26M |
Net tangible assets | -95.79900M | -61.98800M | -25.11500M | -48.97900M | -66.89200M |
Short term investments | - | - | - | - | - |
Net receivables | 55.78M | 40.92M | 43.23M | 50.85M | 55.53M |
Long term debt | 136.39M | 94.97M | 73.36M | 99.43M | 124.58M |
Inventory | 0.78M | 0.85M | 1.08M | 1.43M | 1.50M |
Accounts payable | 7.04M | 8.08M | 7.72M | 8.80M | 5.67M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | - | - | - | -7.05300M | -5.64500M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | 53.92M | 38.05M | 19.62M | - | -5.02400M |
Treasury stock | -14.50000M | -2.57600M | -1.26100M | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 11.44M | 11.11M | 14.26M | 20.04M | 20.26M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 356.40M | 314.35M | 259.13M | 272.76M | 257.81M |
Capital lease obligations | 5.65M | 5.50M | 5.09M | 7.80M | - |
Long term debt total | 136.39M | 94.97M | 73.36M | 99.43M | 124.58M |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Investments | -62.73100M | -69.91900M | -6.66400M | -12.49300M | -0.97800M |
Change to liabilities | 2.89M | 1.48M | 0.56M | 0.54M | -6.21800M |
Total cashflows from investing activities | -62.73100M | -69.91900M | -6.66400M | -12.49300M | -0.97800M |
Net borrowings | 39.71M | 22.25M | -31.56600M | -23.55200M | -11.71000M |
Total cash from financing activities | 25.88M | 20.93M | -37.16400M | -29.48400M | -17.73900M |
Change to operating activities | 3.64M | 4.58M | 4.95M | 0.16M | -10.26000M |
Net income | 15.87M | 18.43M | 14.25M | 20.47M | 17.63M |
Change in cash | -4.48000M | -1.24000M | 5.31M | 1.62M | 5.21M |
Begin period cash flow | 11.43M | 12.67M | 7.36M | 5.73M | 0.52M |
End period cash flow | 6.95M | 11.43M | 12.67M | 7.36M | 5.73M |
Total cash from operating activities | 32.38M | 47.74M | 49.14M | 43.60M | 23.93M |
Issuance of capital stock | - | - | - | - | - |
Depreciation | 23.33M | 16.87M | 13.33M | 12.41M | 12.28M |
Other cashflows from investing activities | -62.46100M | -68.99900M | -3.32800M | -10.73300M | - |
Dividends paid | 0.00000M | 0.00000M | -4.33800M | -5.72900M | 5.62M |
Change to inventory | 0.07M | 0.23M | 0.34M | 0.07M | -0.08100M |
Change to account receivables | -12.42800M | -3.20400M | 3.67M | 0.64M | -3.89800M |
Sale purchase of stock | -11.92400M | -1.31500M | -1.26100M | 0.00300M | - |
Other cashflows from financing activities | 46.64M | 61.00M | 0.07M | 10.80M | 6.89M |
Change to netincome | -0.96300M | 11.86M | 14.33M | 8.18M | 12.53M |
Capital expenditures | 19.37M | 10.29M | 6.66M | 1.76M | 0.98M |
Change receivables | -6.28400M | 4.89M | 10.04M | - | -13.37100M |
Cash flows other operating | 0.61M | -0.88400M | -3.89900M | - | 0.81M |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | -4.48000M | -1.24000M | 5.31M | - | 5.21M |
Change in working capital | -6.19100M | 0.28M | 6.92M | 2.19M | -18.85700M |
Stock based compensation | 5.17M | 5.46M | 7.00M | 9.82M | 9.71M |
Other non cash items | 0.88M | 3.20M | 4.89M | -2.30700M | 3.52M |
Free cash flow | 13.01M | 37.46M | 42.48M | 41.84M | 22.95M |
Sector: Healthcare Industry: Health Information Services
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
CPSI Computer Programs and Systems Inc |
-1.545 16.81% | 7.64 | - | 10.70 | 0.49 | 0.72 | 0.92 | 10.65 |
GEHC GE HealthCare Technologies Inc. |
0.62 0.80% | 77.71 | 22.91 | 20.12 | 2.01 | 5.52 | 2.39 | 13.30 |
VEEV Veeva Systems Inc Class A |
-2.02 0.91% | 219.52 | 54.61 | 33.22 | 12.83 | 6.73 | 11.14 | 58.84 |
MTHRF M3 Inc |
- -% | 9.73 | 29.72 | 25.00 | 0.05 | 4.38 | 0.04 | 0.12 |
MTHRY M3 Inc |
-0.13 2.97% | 4.25 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
Computer Programs and Systems, Inc. provides healthcare information technology solutions and services in the United States and the Caribbean nation of St. Maarten. Its software systems include patient management software that enables a hospital to identify a patient at various points in the healthcare delivery system, as well as to collect and maintain patient information throughout the process of patient care; and financial accounting software, which offers business office applications to track and coordinate information needed for managerial decision-making. The company also provides clinical software that automates record keeping and reporting for various clinical functions, including laboratory, radiology, physical therapy, respiratory care, and pharmacy; patient care applications; and enterprise applications that support its products for use in various areas of the hospital. In addition, it offers Centriq, an intuitive user interface to centralize data from various care areas that provide the end user with a tool to view past and present patient information. Further, the company provides post-acute care software systems; software application support, hardware maintenance, and education and related services; post-acute care support and maintenance services; revenue cycle management products and services, consulting and business management services, and managed information technology services; patient engagement, and encoder solutions. It serves community hospitals and physician clinics, skilled nursing, and assisted living facilities. Computer Programs and Systems, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.
Emanuel Street, Mobile, AL, United States, 36602
Name | Title | Year Born |
---|---|---|
Mr. Christopher L. Fowler | CEO, Pres & Director | 1976 |
Mr. Matt J. Chambless | CFO, Sec. & Treasurer | 1981 |
Mr. David A. Dye | COO & Director | 1970 |
Mr. John Boyd Douglas Jr. | Sr. Advisor | 1967 |
Mr. Troy D. Rosser | Sr. VP of Sales | 1965 |
Mr. Wes Cronkite | Chief Technology & Innovation Officer | NA |
Mr. Kevin Plessner | Gen. Counsel | NA |
Ms. Tracey A. Schroeder | Chief Marketing Officer | NA |
Ms. Dawn M. Severance | Chief Sales Officer | 1970 |
Ms. Amaris A. McComas | Chief People Officer | 1983 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.